FDA endorses psilocybin with Breakthrough Therapy classification
Just months after we dedicated a week to the magnificent mushroom, the FDA has approved psilocybin, the hallucinogenic compound of magic mushrooms, as a Breakthrough Therapy for the second time this year. This designation means research can be fast-tracked into psilocybin’s application for Read More...